Global Ablation Devices Market, By Product (Laser Ablators, Radiofrequency Ablators, Microwave Ablators, Ultrasound Ablators, Electric Ablators, Hydrothermal Ablators, and Cryoablators), Technology Type (Radiofrequency Ablation, Microwave Ablation, Cryoablation, High-Intensity Focused Ultrasound, Laser Interstitial Thermal Ablation,and Others), Function (Automatic and Robotic), Procedure (Tumor Ablation, Varicose Veins, Atrial Fibrillation, Aesthetics-Skin Rejuvenation and Tightening, Laser, and Other Energy Based Therapies), Application (Cancer Treatment, Cosmetic Treatment, Urological Treatment, Orthopedic Treatment, Ophthalmic Treatment, Pain Management, and Others) – Industry Trends and Forecast to 2031.
Ablation Devices Market Analysis and Size
Ablation devices are used in various medical procedures to remove or destroy abnormal or diseased tissue. One of the primary applications of ablation devices is in the treatment of cardiac arrhythmias, such as atrial fibrillation. Ablation devices are also used in the treatment of certain types of cancer, particularly in cases where surgery is not an option. These devices can deliver heat, cold, or other forms of energy to destroy cancerous tissue while minimizing damage to surrounding healthy tissue. These devices are also used in the treatment of conditions such as varicose veins, where they are used to seal off the affected veins, leading to their eventual disappearance.
Global ablation devices market size was valued at USD 9.57 billion in 2023 and is projected to reach USD 22.45 billion by 2031, with a CAGR of 11.25% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2024 to 2031
|
Base Year
|
2023
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
Segments Covered
|
Product (Laser Ablators, Radiofrequency Ablators, Microwave Ablators, Ultrasound Ablators, Electric Ablators, Hydrothermal Ablators, and Cryoablators), Technology Type (Radiofrequency Ablation, Microwave Ablation, Cryoablation, High-Intensity Focused Ultrasound, Laser Interstitial Thermal Ablation,and Others), Function (Automatic and Robotic), Procedure (Tumor Ablation, Varicose Veins, Atrial Fibrillation, Aesthetics-Skin Rejuvenation and Tightening, Laser, and Other Energy Based Therapies), Application (Cancer Treatment, Cosmetic Treatment, Urological Treatment, Orthopedic Treatment, Ophthalmic Treatment, Pain Management, and Others)
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America
|
Market Players Covered
|
Varian Medical Systems Inc. (U.S.), Biosense Webster, Inc. (U.S.), Elekta AB (Sweden), Medtronic (Ireland), Johnson & Johnson Services, Inc. (U.S.), Alcon (Switzerland), Bausch & Lomb Incorporated (U.S.), EDAP TMS (France), Halyard (U.S.), Olympus Corporation (Japan), Abbott (U.S.), AngioDynamics (U.S.), ATRICURE, INC. (U.S.), Boston Scientific Corporation (U.S.), CONMED Corporation (U.S.)
|
Market Opportunities
|
|
Market Definition
Ablation devices are medical instruments used to remove or destroy tissue, typically in a minimally invasive manner. These devices are often used in the treatment of conditions such as cardiac arrhythmias, cancer, and varicose veins. Ablation can be achieved using various energy sources, including radiofrequency, laser, cryotherapy (extreme cold), and microwave.
Ablation Devices Market Dynamics
Drivers
- Increasing Prevalence of Chronic Diseases
With the increasing prevalence of chronic diseases, including cancer and cardiac arrhythmias, there is a pressing need for effective treatment options. Ablation therapy offers a minimally invasive approach to treating certain types of tumors, providing patients with an alternative to traditional surgery or chemotherapy. Similarly, cardiac arrhythmias, which affect millions of people globally, can be effectively treated using ablation procedures. As the incidence of these chronic diseases continues to rise, the demand for ablation devices is expected to increase, driving market growth.
- Growing Demand for Minimally Invasive Procedures
Minimally invasive procedures offer several advantages over traditional surgeries, including shorter recovery times, reduced risk of infection, and less post-operative pain. Ablation devices enable physicians to perform minimally invasive procedures with precision, targeting specific areas of tissue without the need for open surgery. This not only benefits patients by providing a less traumatic treatment option but also allows for shorter hospital stays and a quicker return to normal activities. As the demand for minimally invasive procedures continues to rise, so too does the demand for ablation devices, driving market growth.
Opportunities
- Technological Advancements Enhancing Ablation Devices
Continuous technological advancements in ablation devices, including the development of new energy sources and improved catheter designs, have led to the introduction of more precise, efficient, and safe ablation devices, making the procedures more effective and less invasive. The integration of advanced imaging technologies such as MRI and CT scans has enabled real-time visualization during ablation procedures, enhancing accuracy and reducing complications. In addition, the development of new energy sources such as microwave and cryoablation has expanded the range of conditions that can be treated using ablation therapy. Overall, technological advancements are driving innovation in the ablation devices market, leading to improved patient outcomes and increased adoption of these devices globally.
- Increasing Healthcare Expenditure
As healthcare systems strive to provide high-quality care and innovative treatment options, there is a growing focus on investing in advanced medical technologies such as ablation devices. This increased expenditure is enabling healthcare facilities to procure cutting-edge ablation devices, improve infrastructure, and enhance patient care services. Moreover, the growing emphasis on value-based care and patient outcomes is prompting healthcare providers to adopt efficient and effective treatment modalities such as ablation therapy, creating further opportunities for market growth.
Restraints/Challenges
- Lack of Skilled Healthcare Professionals
The complexity of ablation procedures necessitates skilled healthcare professionals to perform them effectively and safely. However, there is a shortage of such professionals in some regions, which can restrain the growth of the ablation devices market. Ablation procedures require a high level of expertise and training due to the intricate nature of the techniques involved. A shortage of skilled professionals can lead to delays in performing procedures, lower procedural success rates, increased risks for patients, and create challenges for the market.
- High Cost of Ablation Devices Limits Adoption
The cost of purchasing ablation devices, as well as the expenses related to training healthcare professionals and maintaining the equipment, can be prohibitive for healthcare facilities with constrained budgets. Additionally, patients in these regions may struggle to afford the out-of-pocket expenses associated with ablation procedures. The high cost associated with ablation devices and procedures can be a significant barrier to their adoption, particularly in developing regions where healthcare budgets are limited.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In October 2022, PENTAX Medical, a healthcare company specializing in diagnostic and therapeutic endoscopy solutions, launched the C2 CryoBalloon Ablation System in Canada for treating Barrett's Esophagus
- In March 2022, Quantum Surgical received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Epione robot. The Epione robot is designed to plan, target, deliver, and confirm tumor ablation for cancer treatment
Ablation Devices Market Scope
The ablation devices market is segmented on the basis of product, technology type, function, procedure, and application. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Product
- Laser Ablators
- Radiofrequency Ablators
- Microwave Ablators
- Ultrasound Ablators
- Electric Ablators
- Hydrothermal Ablators
- Cryoablators
Technology Type
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- High-Intensity Focused Ultrasound
- Laser Interstitial Thermal Ablation
- Others
Function
- Automatic
- Robotic
Procedure
- Tumor Ablation
- Varicose Veins
- Atrial Fibrillation
- Aesthetics-Skin Rejuvenation and Tightening
- Laser
- Other Energy Based Therapies
Application
- Cancer Treatment
- Cosmetic Treatment
- Urological Treatment
- Orthopedic Treatment
- Ophthalmic Treatment
- Pain Management
- Others
Ablation Devices Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, product, technology type, function, procedure, and application as referenced above.
The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
North America is expected to dominate the market due to several factors including the region's high cancer prevalence, strong purchasing power, continuous technological advancements, and government backing for quality healthcare.
Asia-Pacific is expected to witness significant growth during the forecast period due to the introduction of advanced technologies, enhancement of healthcare infrastructure, and improving economic conditions in emerging economies such as China and India.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2011-2021.
Competitive Landscape and Ablation Devices Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- Varian Medical Systems Inc. (U.S.)
- Biosense Webster, Inc. (U.S.)
- Elekta AB (Sweden)
- Medtronic (Ireland)
- Johnson & Johnson Services, Inc. (U.S.)
- Alcon (Switzerland)
- Bausch & Lomb Incorporated (U.S.)
- EDAP TMS (France)
- Halyard (U.S.)
- Olympus Corporation (Japan)
- Abbott (U.S.)
- AngioDynamics (U.S.)
- ATRICURE, INC. (U.S.)
- Boston Scientific Corporation (U.S.)
- CONMED Corporation (U.S.)
SKU-